Global Embolotherapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Embolotherapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

According to our (Global Info Research) latest study, the global Embolotherapy market size was valued at US$ 4216 million in 2023 and is forecast to a readjusted size of USD 6663 million by 2030 with a CAGR of 6.8% during review period.

Global key players of Embolotherapy include Medtronic, Boston Scientific, etc. Global top 3 companies hold a share over 30%. North America is the largest market, with a share about 35%, followed by Europe and China with the share about 25% and 20%. In terms of product, Microspheres for Embolization is the largest segment, with a share about 40%. And in terms of application, the largest application is Cancer, with a share about 50%.

This report is a detailed and comprehensive analysis for global Embolotherapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Embolotherapy market size and forecasts, in consumption value ($ Million), 2019-2030

Global Embolotherapy market size and forecasts by region and country, in consumption value ($ Million), 2019-2030

Global Embolotherapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030

Global Embolotherapy market shares of main players, in revenue ($ Million), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Embolotherapy

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Embolotherapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, Boston Scientific, Terumo, Penumbra, Inc., Johnson & Johnson, Sirtex, Merit Medical, Varian, Stryker, Jiangsu Hengrui Pharmaceuticals Co., Ltd, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Embolotherapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation

Embolotherapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Microspheres for Embolization
Embolism Particles
Embolic coils
Liquid Embolic Agent
Auxiliary Embolization Material
Others

Market segment by Application
Cancer
Peripheral Aascular Disease
Nerve System Disease
Others

Market segment by players, this report covers
Medtronic
Boston Scientific
Terumo
Penumbra, Inc.
Johnson & Johnson
Sirtex
Merit Medical
Varian
Stryker
Jiangsu Hengrui Pharmaceuticals Co., Ltd
Cook Medical
Kaneka
Meril Life Sciences
Peijia Medical Limited
Wallaby Medical
MicroPort Scientific Corporation
Shandong Visee Medical Devices Co.,Ltd
Beijing Taijie Weiye Technology

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Embolotherapy product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Embolotherapy, with revenue, gross margin, and global market share of Embolotherapy from 2019 to 2024.

Chapter 3, the Embolotherapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Embolotherapy market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Embolotherapy.

Chapter 13, to describe Embolotherapy research findings and conclusion.